When people think about “immune health,” they usually picture the usual suspects: colds, flu season, maybe a CRP blood test if their doctor is feeling ambitious.
But here’s the twist.
A huge part of your immune system is hanging out inside your tissues, including your skeletal muscle, acting like sentinels. Watching. Patrolling. Cleaning up damage. Helping you recover.
And as we age, that muscle-immune relationship can break down in ways most people have never even heard of.
In my conversation with Dr. Anurag Singh, a physician, immunologist, and researcher in the aging and mitochondria space, we unpacked a simple but powerful idea that if your immune system ages poorly, your whole body ages poorly.
And yes… that includes your muscles.
The “Alzheimer’s of Muscle” Problem Nobody Talks About
Most people have heard of sarcopenia, the slow, age-related slide in muscle mass and strength. You get older, you get weaker. Fine.
But what Dr. Singh was pointing to is a different kind of problem. Sometimes muscle doesn’t just shrink. Sometimes it starts to behave like a tissue that’s losing internal order. Almost like the “rules” that keep it healthy and self-repairing begin to fall apart.
A classic example is sporadic inclusion body myositis (sIBM).
On paper, it’s considered “rare.” In real life, it’s probably more common than we think, because it’s frequently missed or misdiagnosed early on. And the early phase can look exactly like normal aging: someone in their 60s starts noticing that getting up from a chair feels harder, their legs feel unreliable, their grip weakens, or they start tripping more than they used to. They chalk it up to “I’m just getting older.” Their doctor might too.
But sIBM tends to have a few features that should make your antenna go up.
First, it often causes slowly progressive weakness that can be asymmetric, meaning one side may weaken faster than the other. Second, the pattern isn’t random. It commonly hits the quadriceps (that “stand up from a chair” muscle group), the deep finger flexors (grip strength and finger function), and the foot extensors (toe lift and gait stability). Over time, it can become relentlessly disabling by progressing toward major mobility loss and, eventually, wheelchair dependency.
Now here’s where the “Alzheimer’s of muscle” framing starts to make sense.
When doctors confirm sIBM with a muscle biopsy, they don’t just see “smaller muscle fibers.” They often see a weird two-track disease process happening at the same time:
- Immune attack inside the muscle. You see immune cells infiltrating the tissue and clustering around muscle fibers as if the muscle is being treated like a target. The muscle fibers may also show signs of abnormal immune signaling (like increased MHCI expression), which is one reason sIBM is often discussed as having an autoimmune component.
- Degenerative, protein-aggregation changes. You also see muscle fibers that look like they’re accumulating junk: vacuoles, misfolded multi-protein aggregates, and other signs of impaired cellular cleanup. That mirrors the broad “protein pileup” theme people associate with neurodegenerative diseases.
Layered into that, many biopsies also show mitochondrial dysfunction, which matters because mitochondria aren’t just “energy factories.” They’re deeply involved in stress signaling, repair capacity, and whether the cell can keep its internal housekeeping systems running.
And that combination of immune dysregulation plus protein aggregation plus mitochondrial dysfunction is exactly why sIBM is so interesting in a longevity conversation. Because it forces a bigger question: What if some cases of “rapid aging” in muscle aren’t just about low protein intake or not lifting weights, but about a deeper collapse in tissue regulation?
It also highlights something important for how we think about muscle decline: strength can fall for more than one reason. Sometimes it’s disuse. Sometimes it’s sarcopenia. And sometimes it’s something more pathological hiding behind the mask of “normal aging.”
One more uncomfortable detail: despite being the most common acquired muscle disease in older adults, sIBM still has no reliably enduring treatment. That doesn’t mean nothing can be done for function and quality of life, but it does mean prevention, early recognition, and protecting muscle health upstream becomes even more valuable.
And it sets up the key transition Dr. Singh kept returning to: If immune dysfunction and mitochondrial dysfunction can team up to break muscle, then preserving muscle across aging isn’t just about training muscle fibers.
It’s about protecting the systems that keep muscle tissue organized in the first place.
Why Immune Aging Might Be the First Domino
One of the most compelling ideas Dr. Singh raised is that immune aging may not be a downstream consequence of getting older, but one of the earliest cracks in the system.
When most people think about immune decline, they think about getting sick more often. More colds. Worse flu seasons. Slower recovery. That’s part of the picture, but it’s not the core problem. What he’s really describing is a systems-level shift in how the immune system is built and how it behaves over time.
This process is known as immunosenescence, and it reflects a gradual erosion of immune reserve capacity. With age, the immune system produces fewer new cells, responds less efficiently to unfamiliar threats, and drifts into a chronic state of low-grade inflammation. Not the dramatic inflammation of infection or injury, but a constant simmer that never fully shuts off and slowly wears tissues down.
A major driver of this shift is the thymus, a small organ behind the breastbone that acts as the immune system’s training center. Early in life, the thymus is highly active, producing naïve T cells that allow the immune system to adapt quickly to new viruses, bacteria, and abnormal cells. But the thymus begins shrinking surprisingly early in adulthood through a process called thymic involution. Functional tissue is gradually replaced with fat, and the organ loses its ability to generate new immune cells.
By midlife, thymic output has declined dramatically. By around age fifty, only a small fraction of its original function remains. The body compensates by recycling existing immune cells to keep total numbers stable, but this comes at a cost. Diversity shrinks. Flexibility disappears. The immune system becomes more reactive and less adaptive, relying on worn-out cells that respond more slowly and less precisely.
At the same time, immune cells don’t simply vanish. Many persist in a dysfunctional state. They remain present but exhausted, less capable of mounting strong responses or coordinating repair. It’s like a security team that’s still on duty but burned out, slow to react, and increasingly prone to false alarms.
This combination of fewer fresh immune cells, rising background inflammation, and functional exhaustion has consequences far beyond infection risk. Immune cells help regulate tissue repair, clear damaged cells, and shape how organs respond to stress. When immune function declines, those processes falter everywhere at once.
That’s why immune aging doesn’t stay isolated. Immune cells patrol nearly every organ, including muscle, brain, liver, and connective tissue. When they become dysregulated, the effects ripple outward, impairing recovery, accelerating degeneration, and reducing resilience across the body.
Studies tracking older adults show that lower thymic activity is associated with substantially higher mortality risk, even over relatively short time frames. In other words, immune aging isn’t just a marker of getting older. It’s a predictor of survival itself.
From an evolutionary perspective, this trade-off once made sense. The thymus is metabolically expensive to maintain, and scaling it back conserved energy in a world where humans rarely lived beyond forty or fifty years. But in a modern context, where we routinely live decades longer, that compromise becomes a liability.
As Dr. Singh framed it, once the immune system begins to erode, the entire body becomes harder to maintain. Muscle repair slows. Mitochondrial dysfunction accumulates. Cancer surveillance weakens. Stress that once led to adaptation now leads to breakdown.
Which is why immune aging may be the first domino to fall. Not because it causes every problem directly, but because when immune regulation falters, the body loses one of its most powerful tools for staying resilient.
The Muscle–Immune Axis: Why Exercise Slows Immune Aging
When Dr. Singh compares muscle tissue from fit older adults to that of frail older adults, a consistent pattern shows up. The biggest biological differences don’t just involve muscle size or strength. They cluster around two deeper issues: mitochondrial dysfunction and immune dysregulation.
That immediately raises a chicken-or-egg problem. Does declining mitochondrial health drive immune dysfunction, or does immune aging damage mitochondria and muscle from the inside out? At this point, the answer appears to be both. These systems are tightly interwoven, and when one begins to fail, the others tend to follow.
This is why “muscle health” can’t be reduced to simply building more muscle. Muscle quality depends on what’s happening inside the tissue: how well mitochondria produce energy, how efficiently damaged components are cleared, and how balanced the local immune environment is. Muscle, mitochondria, and immunity form a three-way relationship that either reinforces resilience or accelerates decline.
The encouraging part is that this relationship is highly responsive to lifestyle. Immune aging and thymic decline are not fixed trajectories. They are strongly shaped by physical activity, which acts as a shared signal across all three systems.
One of the most striking demonstrations of this comes from research where scientists studied older adults who had maintained consistent endurance training for decades. These weren’t elite athletes, but regular cyclists in their fifties, sixties, and seventies who trained habitually. When researchers compared them to sedentary adults of the same age, the differences were dramatic.
The sedentary group showed all the classic features of immunosenescence: fewer naïve T cells, more exhausted memory cells, and a pro-inflammatory immune profile. In contrast, the lifelong exercisers had immune systems that closely resembled those of much younger adults. Their thymus was still actively contributing new immune cells, something that typically declines sharply with age.
What made this particularly compelling is that the differences weren’t subtle. Active older adults had higher levels of cytokines that support thymic health and immune renewal, alongside lower levels of inflammatory signals known to accelerate thymic atrophy. Even the flow of immune progenitor cells into the thymus — the raw material needed to generate new T cells — was preserved at near-youthful levels.
In practical terms, this means these individuals weren’t just slowing immune decline, but were actively maintaining immune adaptability decades longer than expected.
Similar findings show up in less extreme examples. Older adults who simply walk more each day, accumulating ten to fifteen thousand steps instead of three thousand, show better thymic signaling, higher naïve T-cell counts, and a more youthful immune profile.
All of this reinforces a central theme of the conversation: exercise is still the most powerful medicine we have for slowing immune aging. It stimulates mitochondrial renewal through mitophagy and biogenesis, reduces chronic inflammatory signaling, and creates an environment where immune cells remain functional rather than exhausted.
Dr. Singh also emphasized something many people need reassurance about. Mild illness or feeling “a bit off” doesn’t automatically mean you should stop moving altogether. Gentle movement often supports immune regulation rather than suppressing it. The goal isn’t to grind through severe illness, but to avoid prolonged shutdown that accelerates decline.
The bigger pattern is hard to ignore. The longest-lived, healthiest populations don’t rely on hacks or shortcuts. They move regularly. They challenge their bodies just enough. They stay physically engaged with life for decades.
And their immune systems reflect that sustained investment.
The Urolithin A Study: A New Angle on Immune Aging
One of the most interesting pieces of data Dr. Singh shared came from his team’s recent randomized, placebo-controlled trial on urolithin A, a compound best known for its ability to stimulate mitophagy, the cellular process that clears out damaged mitochondria and makes room for healthier ones.
Urolithin A is unusual because it’s not a nutrient you directly consume in meaningful amounts. It’s a postbiotic. Some people can make it from polyphenol-rich foods like pomegranate, but only if they have the right gut microbes. Many people don’t, which means two people can eat the same diet and get very different biological effects.
In this study, healthy middle-aged and older adults took either urolithin A or a placebo for about four weeks. Instead of stopping at broad inflammatory markers, the researchers went much deeper, examining immune cell populations, mitochondrial function inside those cells, and how the immune system behaves under stress.
They paid particular attention to naïve CD8 T cells. Dr. Singh describes these as “youthful responders” or stem-cell-like immune cells that haven’t been worn down by repeated activation. These are the cells that allow you to recognize and respond to new infections, vaccines, and immune challenges. One of the hallmarks of immune aging is the gradual loss of this naïve pool, replaced by exhausted, highly specialized cells that are less flexible and less resilient.
The key finding was that urolithin A appeared to shift the immune system in a more youthful direction.
Participants taking urolithin A showed:
- An expansion of naïve-like, less exhausted CD8 T cells
- Improved mitochondrial features inside immune cells, including greater capacity for fatty acid oxidation
- Increased mitochondrial biogenesis within CD8 T cells
- Increases in other important immune populations, including natural killer cells and non-classical monocytes
But numbers alone weren’t the most compelling part.
The researchers also challenged immune cells in functional tests, essentially asking whether these cells could perform better under stress. In the urolithin A group, immune cells showed improved activation responses and better functional behavior when stimulated.
This is an important distinction. Many interventions reduce inflammation on paper without improving immune competence. What makes this study notable is that the immune system didn’t just look different, it behaved differently.
This doesn’t replace exercise, movement, or metabolic health, and Dr. Singh was clear about that. But it does suggest that targeting mitochondrial health may be one of the more promising complementary strategies for slowing immune decline, especially in people whose immune systems are already drifting toward exhaustion.
It’s a reminder that immune aging isn’t just about fighting germs. It’s about maintaining the capacity to respond, and that capacity appears to be tightly linked to mitochondrial health deep inside the cell.
The Lab Markers People Can Actually Use Now
This is the part everyone eventually asks about: How do I measure any of this in the real world?
There is no simple, consumer-ready test that tells you how old your immune system is or how well your mitochondria are functioning inside specific immune cells. The most informative tools exist in research labs and they’re expensive, specialized, and not something your primary care doctor can order at a routine visit.
But that doesn’t mean you’re flying blind. There are a few basic markers that can still offer useful signal when interpreted in context and tracked over time.
A standard complete blood count gives you a total white blood cell count. On its own, that number doesn’t tell you much. But trends matter. A slow drift downward with age can reflect shrinking immune reserve, while chronically elevated levels can point to ongoing inflammation, infection, or immune dysregulation.
Differential counts add another layer. Looking at lymphocytes specifically is often more informative than total white cells alone. Lymphocytes include T cells, B cells, and natural killer cells, which are the backbone of adaptive and innate immune responses. Persistently low lymphocyte counts have been associated with frailty, infection risk, and higher mortality in older adults. Again, the goal isn’t to maximize numbers, but to avoid silent erosion.
Inflammatory markers like hs-CRP provide good context. Chronic low-grade inflammation is one of the hallmarks of immune aging. An elevated hs-CRP doesn’t tell you why inflammation is present, but it does tell you that the immune system is operating in a more reactive, stressed state that accelerates thymic decline and immune exhaustion over time.
Dr. Singh emphasized that none of these markers should be viewed in isolation. A single lab value is a snapshot. What matters is pattern and trajectory. Are immune counts slowly falling year over year? Is inflammation persistently elevated despite reasonable lifestyle habits? Do changes correlate with declining physical function, slower recovery, or increased susceptibility to illness?
These labs don’t diagnose immunosenescence. They don’t measure mitochondrial health directly. But they can act as early warning lights. Waiting until something “breaks” often means you’re intervening far downstream.
So while we wait for better tools to make their way into clinical practice, these basic markers offer something valuable: a way to stay aware, track change, and ground conversations about immune health in data rather than guesswork.
The Big Takeaway
If there’s one theme that kept surfacing in this conversation, it’s that longevity isn’t just about having muscle. It’s about whether your muscle can stay repairable.
Muscle that can’t repair is muscle that eventually fails. Strength fades. Recovery slows. Inflammation lingers. And what looks like “normal aging” often turns out to be a system that’s lost its ability to adapt.
That repair capacity depends on mitochondria, immune regulation, and whether those systems are being regularly signaled to stay online. This reframes how we think about aging entirely. It’s not just a story of loss. It’s a story of underuse.
So the real question becomes: Are you training your body like you plan to keep it? Or are you treating it like something you’ll use until your joints hurt, your energy drops, or your immune system quietly checks out?
Action Checklist
If you want better immune aging, better muscle aging, and better long-term resilience, start here.
- Move consistently and don’t make it complicated. Aim for a baseline routine you can sustain: walking, resistance training, or a mix. Consistency beats intensity spikes.
- Strength train to protect muscle and immune function. Muscle isn’t just for aesthetics. It’s metabolic tissue, immune-active tissue, and a major driver of resilience as you age.
- Prioritize mitochondrial-supportive habits. Exercise is the most reliable lever. But also consider sleep, stress management, and avoiding chronic overfeeding.
- Support your gut like it matters (because it does). The ability to produce helpful postbiotics depends on microbial health. Foods matter, but so do patterns: fiber, diversity, and minimizing constant ultra-processed intake.
- Check a few basic labs yearly and don’t fly blind. Ask your physician about: CBC with differential (including lymphocytes) and hs-CRP. Not as “perfect answers,” but as trend markers.
- Be cautious with “longevity shortcuts” that ignore muscle. Anything that reduces appetite or bodyweight without protecting lean mass can backfire long-term if it accelerates frailty.
- If you use supplements, use them to support fundamentals, not replace them. Supplements may help “raise the floor,” but they’re not a substitute for strength, movement, and metabolic health.
